13-Jan-2010 | business & finance
Sanofi Pasteur Partners with KaloBios on Novel Biologic for the Prevention and Treatment of Pseudomonas aeruginosa Infections
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced an agreement with KaloBios
Pharmaceuticals for the development of a Humaneered ...